224 related articles for article (PubMed ID: 15846168)
1. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies.
Raboisson MJ; Fouron JC; Sonesson SE; Nyman M; Proulx F; Gamache S
J Am Soc Echocardiogr; 2005 Apr; 18(4):375-80. PubMed ID: 15846168
[TBL] [Abstract][Full Text] [Related]
2. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
Nield LE; Silverman ED; Taylor GP; Smallhorn JF; Mullen JB; Silverman NH; Finley JP; Law YM; Human DG; Seaward PG; Hamilton RM; Hornberger LK
Circulation; 2002 Feb; 105(7):843-8. PubMed ID: 11854125
[TBL] [Abstract][Full Text] [Related]
3. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block.
Nield LE; Silverman ED; Smallhorn JF; Taylor GP; Mullen JB; Benson LN; Hornberger LK
J Am Coll Cardiol; 2002 Aug; 40(4):796-802. PubMed ID: 12204513
[TBL] [Abstract][Full Text] [Related]
4. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
Keller SB; Cohen J; Moon-Grady A; Cuneo B; Paul E; Coll AC; Campbell M; Srivastava S
Ultrasound Obstet Gynecol; 2023 Jul; 62(1):148-151. PubMed ID: 36806323
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
[TBL] [Abstract][Full Text] [Related]
6. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
[TBL] [Abstract][Full Text] [Related]
7. Fetal echocardiographic assessment of endocardial fibroelastosis in maternal anti-SSA antibody-associated complete heart block.
Aoki H; Inamura N; Kawazu Y; Nakayama M; Kayatani F
Circ J; 2011; 75(5):1215-21. PubMed ID: 21436591
[TBL] [Abstract][Full Text] [Related]
8. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
[TBL] [Abstract][Full Text] [Related]
10. Conduction system disease in fetuses evaluated for irregular cardiac rhythm.
Cuneo BF; Strasburger JF; Wakai RT; Ovadia M
Fetal Diagn Ther; 2006; 21(3):307-13. PubMed ID: 16601344
[TBL] [Abstract][Full Text] [Related]
11. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
Sonesson SE; Ambrosi A; Wahren-Herlenius M
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
[TBL] [Abstract][Full Text] [Related]
12. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
[TBL] [Abstract][Full Text] [Related]
13. Discordant spectrum of cardiac manifestations of neonatal lupus in twins.
Killen SA; Buyon JP; Friedman DM
Lupus; 2012 Apr; 21(5):559-62. PubMed ID: 22140143
[TBL] [Abstract][Full Text] [Related]
14. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies.
Guettrot-Imbert G; Cohen L; Fermont L; Villain E; Francès C; Thiebaugeorges O; Foliguet B; Leroux G; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
J Rheumatol; 2011 Feb; 38(2):378-86. PubMed ID: 21078712
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
Saleeb S; Copel J; Friedman D; Buyon JP
Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune-mediated congenital heart block.
Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P
Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414
[TBL] [Abstract][Full Text] [Related]
17. Doppler fetal echocardiography in endocardial fibroelastosis.
Weiner Z; Shalev E
Obstet Gynecol; 2001 Nov; 98(5 Pt 2):933-5. PubMed ID: 11704210
[TBL] [Abstract][Full Text] [Related]
18. Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies.
Wang X; Liu XW; Han L; Li MT; Zhao JL; Sun L; Han JC; Zeng XF; Tian XP; Zhao Y; He YH
Front Pediatr; 2022; 10():904138. PubMed ID: 35967560
[TBL] [Abstract][Full Text] [Related]
19. Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome.
McElhinney DB; Vogel M; Benson CB; Marshall AC; Wilkins-Haug LE; Silva V; Tworetzky W
Am J Cardiol; 2010 Dec; 106(12):1792-7. PubMed ID: 21126622
[TBL] [Abstract][Full Text] [Related]
20. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]